US Patent 11168322 CRISPR RNA targeting enzymes and systems and uses thereof
Patent 11168322 was granted and assigned to Arbor Biotechnologies on November, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+287 characters)
Article
Patent abstract
The disclosure describes novel systems, methods, and compositions for the manipulation of nucleic acids in a targeted fashion. The disclosure describes non-naturally occurring, engineered CRISPR systems, components, and methods for targeted modification of a nucleic acid.
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 2 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
111683220
Date of Patent
November 9, 2021
0Patent Application Number
201803080
Date Filed
March 8, 2018
0Official Website
Patent Primary Examiner
Edits on 22 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
111683220
Date of Patent
November 9, 2021
0Patent Application Number
201803080
Date Filed
March 8, 2018
0Official Website
Patent Primary Examiner
Edits on 7 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 11 Nov, 2021
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 11168322 CRISPR RNA targeting enzymes and systems and uses thereof
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11168322
Date of patent
November 9, 2021
Patent application number
20180308
Date Filed
March 8, 2018
Patent primary examiner
Find more entities like US Patent 11168322 CRISPR RNA targeting enzymes and systems and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
